In vitro synthesized 5' portions of mouse 18S rRNA are cleaved efficiently at a specific site in partially purified extracts of mouse FM3A cells and several mouse tissues. This activity is composed of both protein and RNA, and can be reconstituted with the protein component in micrococcal nuclease-treated extracts and the RNA component in phenol-treated ones. The RNA component of about 65 nucleotides with the complementing activity was purified from total RNA in the partially purified FM3A cell extracts by polyacrylamide gel electrophoreses. Chemical sequencing of this RNA elucidated that it is tRNA Ar 9 lacking nine nucleotides from its 3' terminus. Ribonuclease H treatment directed by deoxyoligonucleotides complementary to tRNA Ar 9 completely abolishes the cleavage activity, supporting the above conclusion.
INTRODUCTION
Transfer RNA plays an important role as an adaptor in the translation of genetic information from nucleic acid to protein. Many biological systems utilize tRNA for various other functions besides translation. Several tRNAs are used as primers for reverse transcription of retrovirus genomic RNA (1, 2) . A chloroplast tRNA Glu is required for the biochemical transformation of glutamate to 5-aminolevulinic acid (3) . The E.coli dnaY gene essential for DNA replication encodes an arginine tRNA (4) . A tRNA^s-dependent post-translational conjugation of arginine to acidic NH 2 termini of proteins is essential for their degradation via the ubiquitin pathway (5) . A tRNA Gly mediates specific incorporation of glycine into bacterial lipopolysaccharide (6) . The major RNA in prosomes of HeLa cells and duck erythroblasts is tRNA L y s ' 3 , the precise function of which is not yet known (7) . It has been also shown that tRNA is involved in an endoribonuclease activity (8) . This novel spermidine-dependent, sequence-specific endoribonuclease has been found in mouse FM3A cell extracts and designated as RNase 65 (9) . This ribonuclease preferentially cleaves RNA substrates containing a target sequence CCCCCdGUUUGU between its two successive guanosines (10) . In addition to a protein component, the RNase 65 activity requires tRNA lacking its 3' terminus, which is identified as either tRNA Gll \ tRNA G| y or tRNA Met (8) . Recendy, it has been shown that the RNase 65 activity is abolished by RNase H treatment directed by antisense deoxyoligonucleotides to tRNA 01 ? and that the tRNA component of RNase 65 can be partially purified with a deoxyoligonucleotide comlementary to tRNA G1 >' (11) . A completely homogeneous tRNA preparation is, however, needed to determine which species is the exact tRNA component. Although no precise physiological function can as yet be ascribed to RNase 65 which localizes in cytosol, the activity might be involved in specific RNA degradation (10) .
In order to investigate genuine target RNAs of RNase 65, I synthesized various RNA substrates from cloned genes and cDNAs using in vitro transcription systems and performed the endoribonuclease assay with these substrates. In the course of this study, I have found an efficient in vitro cleavage of partially synthesized mouse 18S rRNA, which occurs at a specific site in a very different sequence from the above 12-nucleotide RNase 65 target. I have also demonstrated that this new cleavage activity requires another RNA species that is a tRNA Ar s lacking its 3' terminus.
MATERIALS AND METHODS
RNA substrates 50-, 168-and 344-nucleotide (nt) RNA substrates were synthesized with SP6 RNA polymerase (Takara Shuzo) from Xbal-, Hinfl-and BamHI-digested pSPC, respectively ( Figure 1A ). The transcription reaction was performed under the condition specified by the manufacturer with or without [a-32 P]UTP (Amersham Japan). The transcripts were purified by denaturing polyacrylamide gel electrophoresis. The cold transcript was then 3'-end-labeled with [5'-32 P]pCp and further gel-purified. All DNA restriction endonucleases were purchased from Takara Shuzo.
Preparation of cell extracts
Brains, thymuses, lungs, livers, and kidneys were removed from mice killed after ether narcosis by cervical dislocation. Total S100 extracts of the mouse tissues and mouse FM3A cells were prepared as described previously (10) .
Endoribonuclease assay Fractionation of the total S100 extracts by phosphocellulose column chromatography was also carried out as previously described (10) and a 0.1 M KC1 flow-through fraction (PA * Present address: Life Science Research Laboratory, Japan Tobacco Inc., 6-2 Umegaoka, Midori-ku, Yokohama, Kanagawa 227, Japan fraction) was used for endoribonuclease assay. A standard endoribonuclease assay was performed under conditions as follows. The standard reaction mixture (25 /tl) contained 5 /d of the PA fraction (1 ;tg protein per /d) in a solution containing 10 mM Hepes (pH 7.9), 0.33 mM DTT, 3.2 mM spermidine, 0.002-0.005 pmol RNA substrates. After incubation at 50°C for 60 min, RNAs were extracted with phenol, precipitated with ethanol and analyzed on a 5% or 10% polyacrylamide-8 M urea gel. The gel was autoradiographed overnight at -70°C with an intensifying screen.
Complementation test
The PA fraction of the total S100 extracts was pretreated with 5 units//d micrococcal nuclease (Sigma) at 30°C for 30 min in the presence of 1 mM CaCl 2 . The nuclease was then inactivated by adding 0.02 volume of 100 mM EGTA (pH 8.0).
Total RNA in the PA fraction was extracted with phenol, precipitated with ethanol and redissolved in water. A portion of the RNA was treated at 37°C for 30 min with 0.1 /ig//tl RNase A (Sigma) in a 50-//1 reaction mixture containing 10 mM Tris-HCl (pH 8.0) and 1 mM EDTA or with 0.1 /tg/pl DNase I (Takara Shuzo) in a 50-/tl reaction mixture containing 50 mM Tris-HCl (pH 7.5), 10 mM MgCl 2 and 50 /ig/ml bovine serum albumin, subsequently phenol-extracted, ethanol-precipitated and redissolved in the same volume of water as the original PA fraction. Another portion of the RNA was fractionated by affinity chromatography and polyacrylamide gel electrophoreses.
Complementation test was performed under the above standard assay conditions with the MN-pretreated PA fraction (5 pi) and the RNA extracted from the PA fraction instead of the intact PA fraction.
3-end labeling and RNA sequencing
Synthesis of [5'-32 P]pCp by phosphorylation of 3'-CMP with [ 7 _32pj AT p (j CN Biomedicals) and T4 polynucleotide kinase (Nippon Gene), and 3'-end labeling of RNA with [5'-32 P]pCp and T4 RNA ligase (Takara Shuzo) were carried out as described by England et al. (12) .
Chemical RNA sequencing was performed according to the method of Peattie (13) . Sequencing by limited RNase digestion and partial alkali digestion (14) was carried out with RNases Tl, U2, PhyM, B. cereus, and Nuclease Ml (Pharmacia) under the conditions recommended by the manufacturer.
Two-dimensional thin layer chromatography
A cold 111-nt 5' product generated by specific cleavage of the 168-nt RNA substrate was 3'-end-labeled with [5'-32 P]pCp, gelpurified and digested completely with 0.2 units//d RNase T2 (Sankyo Chemical) in a 10-/d reaction mixture containing 10 mM ammonium acetate (pH 4.6) and 0.5 pg/pl yeast tRNA at 37°C for 8 hr.
32 P-labeled nucleoside 3'-monophosphate was analyzed by two-dimensional thin layer chromatography with isobutyric acid/0.5 M ammonia (5:3, by vol.) for the first dimension and isopropyl alcohol/36% HCl/water (70:15:15, by vol.) for the second dimension, and the chromatogram was subsequently autoradiographed (15) .
tRNA fractionation by affinity chromatography
The following deoxyoligonucleotide with Aminolink 2 (Applied Biosystems) at the 5' terminus that is complementary to nucleotide sites 16 to 45 of human glycine tRNAocc (16) was synthesized on the DNA synthesizer (Applied Biosystems) and gel-purified:
5 '-CCTCCCGCGTGGCAGGCGAGAATTCTACCA-3'. CH Sepharose 4B (Pharmacia) was coupled with this oligonucleotide in the presence of l^myl(3-dimemyl-ainino-propyl)carbodiirnide hydrochloride, and subsequendy, unreacted groups on the Sepharose were blocked with 1 M ethanolamine as directed by the manufacturer. Heat-denatured total tRNA (120 pg) from the PA fraction of mouse FM3A cell extracts was applied to the Sepharose affinity column with 500 pg of the anti-tRNA 0^- oligonucleotide equilibrated with a buffer (0.8 M NaCl, 10 mM Tris-HCl (pH 8.0), 1 mM EDTA). A flow-through fraction (110 pg) with this buffer and a bound fraction (1 pg) eluted widi another buffer (7 M urea, 10 mM Tris-HCl (pH 8.0), 1 mM EDTA) were emanol precipitated and dissolved in water.
tRNA purification by polyacrylamide gel electrophoresis The RNA fraction not bound to the anti-tRNA^-oligonucleotide-Sepharose was labeled with [5'-32 P]pCp and then separated by electrophoresis through a 60 cm 10% polyacrylamide-8 M urea gel. RNA fractions eluted from die gel slices were ethanol precipitated and used for the complementation assay. An approximately 65 nt-RNA fraction positive in the assay was applied to second electrophoresis through a 60 cm nondenaturing 10% polyacrylamide gel. RNA fractions were likewise tested for complementation. A positive RNA fraction was further resolved on a 60 cm nondenaturing 5% polyacrylamide gel and highly purified RNA fractions were obtained for the subsequent complementation assay. A single RNA species positive in me last assay was used for RNA sequence analysis.
RNase H treatment
The PA fraction of the total S100 extracts of mouse FM3A cells was first treated in the presence of 4 mM MgCl 2 with 1 units/^1 of RNase H (Takara Shuzo) and 6 pM deoxyoligonucleotides at 30°C for 20 min. The oligonucleotides were synthesized on an Applied Biosystems DNA Synthesizer. After addition of EDTA to 20 mM, the endoribonuclease assay was performed under the standard conditions.
RESULTS

Specific cleavage of partially synthesized 18S rRNA
168-and 344-nt RNA substrates containing 5' portions of mouse 18S rRNA were produced using SP6 RNA polymerase from Hinfl-and BamHI-digested pSPC, respectively ( Figure 1A ). After incubation of the substrates with a 0.1 M KC1 flow-through fraction in phosphocellulose column chromatography (PA fraction) of mouse FM3A cell extracts in the presence of spermidine under the standard conditions, the products were analyzed by denaturing polyacrylamide gel electrophoresis. Both 168-and 344-nt RNA substrates were cleaved very efficiently at the same single site to generate a 111-nt 5' product and a 57-nt 3' product, and a 111-nt 5' product and a 233-nt 3' product, respectively ( Figure IB) .
Another cleavage of the 168-nt RNA substrate in the RNase 65 target sequence yielding a 35-nt 5' product and a 133-nt 3' product was also detected very faintly in a heavily exposed autoradiogram ( Figure 4B, lane 2) . This inefficient cleavage, when compared with the 50-nt RNA substrate ( Figure 4A , lane 2), is probably due to very stable folding at the RNase 65 target site found in a calculated free energy minimum secondary structure (data not shown). The new cleavage activity consists of both protein and RNA components The new cleavage in the 18S rRNA was spermidine-dependent and not detected without the PA fraction of mouse FM3A cell extracts (data not shown). This new activity was abolished by micrococcal nuclease (MN)-pretreatment or phenol-extraction of the PA fraction, and reconstituted by mixing the MN-pretreated PA fraction and the phenol-extracted one ( Figures 1C and 3) . The MN-abolished activity was not restored by yeast total tRNA (data not shown). The complementing activity of the phenolextracted PA fraction was lost by the subsequent RNase A treatment, but not by the subsequent DNase I treatment ( Figure 1C ). These results show that the new activity requires both protein and RNA components. The above properties are the same as those of the RNase 65 activity (9, 10).
A new target sequence is different from that of RNase 65
The precise new cleavage site was determined by enzymatic RNA sequencing and two-dimensional thin layer chromatography ( Figure 2 ). The 168-nt RNA substrate synthesized without [a-32 P]UTP was 3'-end-labeled with [5'-32 P]pCp and cleaved under the standard conditions in the PA fraction of mouse FM3 A cell extracts to yield the 111-nt cold 5' product and the 57-nt hot 3' product ( Figure 4C, lane 2) . 5'-terminal sequence of the 3' product isolated from a gel after electrophoretic resolution was directly determined by limited specific digestions (Figure 2A ). Although about a half number of the 3' products contained a single untemplated 3' nucleotide which originated from the property of SP6 RNA polymerase (17) , overlapping sequence ladders of the two species were readable and the cleavage site in the 18S rRNA (18) was identified ( Figure 1A) . The 111-nt cold 5' product recovered from a gel slice was able to be 3'-endlabeled by ligation reaction with [5'-32 P]pCp, which indicates that the cleavage generates the 5' product with 3'-hydroxyl terminus. The labeled 5' product was completely digested with RNase T2 to generate nucleoside 3'-monophosphate, which was then analyzed by two-dimensional thin layer chromatography. Figure 2B shows that the 3' nucleoside of the 5' cleavage product is uridine. This is consistent with the site determined above compared with the sequence of the 18S rRNA (18 surrounding the cleavage site was very different from the RNase 65 target ( Figure 1A ).
The new cleavage activity in mouse tissues
The new cleavage activity in several mouse tissues was investigated using PA fractions of their total S100 extracts and the 168-nt RNA substrate. The cleavage activity to yield the 111-and 57-nt products was detected in the PA fractions of all examined tissues ( Figure 3A ). In thymus, lung and liver, however, it was not clear that the activity is identical to that in FM3A cells because the same size products in addition to several other cleavage products probably by other ribonucleases were observed even in MN-pretreated PA fractions ( Figure 3B ). To clarify this point, I tested the protein and RNA components in the tissue cells for complementing activity to those in FM3A cells using the MN-pretreated PA fractions and RNAs extracted from the intact PA fractions. The MN-abolished activity in the PA fractions of cell extracts of brain and kidney was distinctly restored by the RNA from FM3A cells, while specific enhancement of the cleavage activity to generate the 111-and 57-nt products was observed in the assay with the MN-pretreated PA fractions from the other tissues supplemented by the RNA from FM3A cells ( Figure 3B ), demonstrating that all these tissues contain the protein component of the specific cleavage activity. Likewise, the existence of the active RNA component in every tissue was shown by the observation that the MN-abolished activity in the PA fraction of FM3A cell extracts was restored by the RNA from every tissue ( Figure 3C ), which solely did not possess the activity ( Figure 3D ). These results confirm that the new specific cleavage activity that consists of protein and RNA exists in all mouse tissues examined. The cleavage activity was also found in rat liver extracts and HeLa cell extracts, but not in yeast cell extracts (data not shown).
Another RNA species is required for the new specific cleavage activity The sequence adjacent to the specific cleavage site in the 18S rRNA had seven different nucleotides out of twelve from the RNase 65 target ( Figure 1A ), while two RNA substrates with three nucleotide substitutions in the RNase 65 target sequence have been shown not to be cleaved at all (10) . This suggested that another tRNA species might be involved in the new cleavage activity for recognition of the new substrate sequence via Watson-Crick base-pairing as discussed previously (10) . To elucidate this point, I fractionated total tRNA from the PA fraction of mouse FM3A cell extracts by affinity chromatography using a deoxyoligonucleotide complementary to a portion of tRNA G1 y, because the tRNA component of the RNase 65 activity can be partially purified by this chromatography (11) . A bound fraction of the total tRNA restored the MN-abolished RNase 65 activity to the 50-nt RNA substrate very efficiently, but a flow-through fraction did not at all ( Figure 4A ). The very weak cleavage at the RNase 65 target site of the 168-nt RNA substrate to yield the 35-and 133-nt products, which vanished by MN-treatment, was highly enhanced by addition of the bound tRNA fraction, while it restored only slightly the MN-abolished activity at the new cleavage site to generate the 57-and 111-nt products ( Figure 4B ). On the other hand, the flow-through tRNA fraction revived efficiently the MN-lost cleavage activity at the new site to yield the 57-nt 3' product and the 111-nt 5' product, which was not detectable in an autoradiogram because the 168-nt RNA substrate used was 3'-end-labeld with [5'-32 P]pCp ( Figure 4C ). The very faint cleavage at the RNase 65 target site to yield the 32 P-labeled 133-nt 3' product and the cold 35-nt 5' product, which was abolished by MN-pretreatment, was hardly restored by addition of the flow-through fraction ( Figure 4C ). Therefore, I concluded that die RNA component of the new cleavage activity is a different RNA species from that of RNase 65.
The other RNA species is arginine tRNA ACG lacking its 3' terminus To purify the new RNA species, the tRNA mixture not bound to anti-tRNA by denaturing polyacrylamide gel electrophoresis. As shown in Figure 6 , 59 nucleotides were identical to those in mouse arginine tRNA ACG (19) when modification was not taken account of. That RNA, however, did not have nine nucleotides of tRNA^s from the 3' terminus. Four nucleosides at sites 27, 39, 54 and 55 could not be identified due to absence of detectable bands. This is consistent with die fact diat the nucleosides in tRNAĉ orresponding to these four sites are pseudouridines, because the pseudouridines cannot be detected by die chemical RNA sequencing mediod. Two species of mouse arginine tRNA ACG with only one nucleoside variation at position 50, cytidine or pseudouridine have been reported (19) . I could not determine which species is the real RNA component because sequence compression around nucleotide site 50 of several tRNA species, The specific cleavage activity after oligonucleotide-directed RNase H treatment. The PA fraction of the total S100 extracts of mouse FM3A cells was pretreated with RNase H in the absence (lane 3) or in the presence of the deoxyoligonucleotides indicated in Figure 6B (lanes 4 to 9). After addition of EDTA, this pretreated PA fraction was incubated with the 168-nt RNA substrate under the standard conditions. The products were resolved on a 5% polyacrylamide-8 M urea gel. Input RNA (lane 1) and the RNA products after incubation with the untreated PA fraction (lane 2) are also shown. Arrowheads denote 111-and 57-nt cleavage products.
which probably results from the T^C stem-loop structure, is observed (data not shown). In any case, the RNA component essential for the specific cleavage of the partially synthesized 18S rRNA was shown to be arginine tRNA ACG lacking nine nucleotides from its 3' terminus.
The speciiic cleavage is abolished by oligonucleotide-directed RNase H digestion I next carried out deoxyoligonucleotide-directed RNA cleavage experiments with RNase H. Six oligonucleotides containing sense or antisense sequences of tRNA^s were synthesized and gelpurified ( Figure 6B ). The PA fraction was pretreated with each deoxyoligonucleotide and RNase H in the presence of MgCl 2 at 30°C for 20 min and the reaction was stopped by addition of EDTA. The 168-nt RNA substrate was incubated with the pretreated PA fraction and the products were analyzed on a denaturing polyacrylamide gel. The new specific cleavage activity in the PA fraction pretreated with the deoxyoligonucleotide (A2, A4 or A6) containing the antisense sequence was completely abolished, while the pretreatment with the sense deoxyoligonucleotide (Al, A3 or A5) had a little effect on the activity (Figure 7 ). This result supports that the new RNA component of the specific cleavage activity is tRNA^s.
DISCUSSION
In this study, I have shown that partially synthesized 5' portions of the 18S rRNA are cleaved in vitro at a specific site in a tRNA Ar £-dependent manner. This new cleavage activity also localizes in cytosol like the RNase 65 activity (data not shown). Although protein components of both activities are eluted in the same fraction in Mono Q column chromatography (data not shown), it is not yet clear whether a protein component of the new activity is identical to that of RNase 65. The existence of the two spermidine-dependent endoribonuclease activities that require different tRNA species suggests that some other tRNA species lacking their 3' termini are also involved in ribonucleolytic cleavage in their own target RNA sequences.
In vitro specific cleavage of the full-length 18S rRNA extracted from mouse FM3A cells was not detected (data not shown), probably because of a stable folding structure at the target site. It is not yet known whether the 18S rRNA interacting with many proteins is a real in vivo target of the new activity. If so, RNA unfolding and protein removal at the target site may be required for the specific cleavage. In any case, finding genuine target RNAs of this new activity as well as the RNase 65 activity and elucidating their physiological functions are of great interest. Further in vivo studies will be fruitful.
While the new endoribonuclease activity occurred in every investigated mouse tissue, the degree of its intensity varied very much (Figure 3) . The degree of its activity may be regulated by quantities of both protein and tRNA components. Although in the complementation test performed with the MN-pretreated PA fraction of FM3A cell extracts and RNA extracted from the PA fraction of each tissue extracts (Figure 3C ), the additional RNA was fixed to a definite amount, the RNAs from the various tissues differed conspicuously in the complementing ability. This result suggests that ratios of the active tRNA component of the endoribonuclease to total tRNA vary from tissue to tissue. As will be discussed below, the active arginine tRNA component may need to be truncated nine nucleotides from its mature 3' terminus and also may need to be modified. Thus, the endoribonuclease activity might be partly regulated by degree of both the 3' terminal truncation and the nucleoside modification of the arginine tRNA. Furthermore, the amount of the truncated arginine tRNA for the specific RNA cleavage may need to be controlled to balance with that of mature tRNA Ar « both for protein synthesis and for a post-translational conjugation of arginine to acidic amino termini of proteins prior to their degradation by the ubiquitin pathway (5) .
The tRNA component of this new activity lacks nine nucleotides from its 3' terminus like that of RNase 65 (8) .
